2 0 2 5年9月2 9日，北京市科学技术 委员会、中关 村科技园区管理委员会联合发布通知， 以"揭榜挂帅"方式向社会公开征集2 0 2 5年 度生物样本库建设技术攻关项目 。 此次发布的榜单涵盖 基因测序平台、蛋白质组学检测平台以及人工智能随访系统 三大方向，旨 在推动生物样本库建设，提升生物医药领域的创新能力和核心竞争力。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 一、基因测序平台 基因测序平台的建设目标是建立高通量基因测序平台，实现从样本到数据的全流程自动化。该平台需具备以下关键指标： 自动化水平：全流程自动化，包括自动样本前处理和文库建库系统。 通量要求：测序读长不低于1 5 0 b p，兼容靶向测序、全基因组测序及全基因组甲基化测序。 数据质量：人全基因组测序有效测序平均深度为3 0 - 3 5X，PE1 5 0平均测序质量Q3 0≥8 5%，基因组比对率≥9 9%。 生信分析能力：日处理能力不少于1 2 0人份全基因组测序数据。 成本控制：以5万例样本为测算依据，探索单样本基因测序极限成本。 考核指标包括建立完整的基因测 ...

Core Points - The Shandong Provincial Science and Technology Conference recently held in Jinan recognized the winners of the 2024 Shandong Provincial Science and Technology Awards, with Binzhou Medical University achieving a record number of awards, including one Youth Award and two Second-Class Progress Awards [1][7] Group 1: Awards and Achievements - Binzhou Medical University won four provincial science and technology awards, including one Shandong Provincial Science and Technology Youth Award, two Second-Class Progress Awards, and one First-Class Technology Invention Award as a participating unit [1] - Professor Tian Geng received the Shandong Provincial Science and Technology Youth Award for establishing advanced platforms for real-time monitoring of cell membrane biological functions and promoting precision diagnosis and treatment technologies for tumors [2] - The Second-Class Progress Award for "Key Technology Innovation and Application of Systematic Characterization and Quality Control of Chemical Components in Traditional Chinese Medicine" was led by Professor Zhang Jiayu, significantly enhancing the discovery of novel trace components in traditional Chinese medicine [3] - Professor Zhang Guilong's project on "High-Resolution Visualization Imaging Technology Innovation and Promotion Application Based on Functional Magnetic Resonance Imaging Probes" also received a Second-Class Progress Award, contributing to non-invasive diagnostic methods for liver damage [4] - The First-Class Technology Invention Award was awarded for the project "Core Key Technology and Application of Novel Dual-Target Receptor-Fc Fusion Protein Drugs," led by Professor Jiang Jing, which developed two globally innovative dual-target fusion protein drugs [5] Group 2: Institutional Focus and Strategy - In recent years, Binzhou Medical University has actively implemented a technology innovation-driven development strategy, focusing on ecological protection and high-quality development in the Yellow River Basin, leveraging its advantages in health and biomedicine [6] - The university has established several distinctive research platforms and gathered strong research teams to support key technological advancements and provide significant support for industrial transformation and upgrading [6] - The university's approach to technology award applications emphasizes early planning and comprehensive support throughout the application process, enhancing the quality of submission materials [6]